Data files for Pulliam, JRC, C van Schalkwyk, N Govender, A von Gottberg, C Cohen, MJ Groome, J Dushoff, K Mlisana, and H Moultrie. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. DOI: 0.1126/science.abn4947 For code and more details see: https://github.com/jrcpulliam/reinfections/releases/tag/v3.0 or 10.5281/zenodo.5807591 ts_data.csv - national daily time series of newly detected putative primary infections (cnt), suspected second infections (reinf), suspected third infections (third), and suspected fourth infections (fourth) by specimen receipt date (date) demog_data.csv - counts of individuals eligible for reinfection (total), who have 0 suspected reinfections (no_reinf) or >0 suspecte...
OBJECTIVE: We aimed to compare clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlie...
Background: At present, it is unclear whether the extent of reduced risk of severe disease seen with...
BACKGROUND: The extent to which the reduced risk of severe disease seen with SARS-CoV-2 Omicron is d...
Data files for Pulliam, JRC, C van Schalkwyk, N Govender, A von Gottberg, C Cohen, MJ Groome, J Dush...
This version contains a single file, with time series data for the most recent monthly report on SAR...
This version contains a single file, with time series data for the most recent monthly report on SAR...
This version contains a single file, with time series data for the most recent monthly report on SAR...
This version contains a single file, with time series data for the most recent monthly report on SAR...
This version contains a single file, with time series data for the most recent monthly report on SAR...
This release is associated with Version 2 of the following preprint: Pulliam, JRC, C van Schalkwyk, ...
This release is associated with Version 3 of the following preprint: Pulliam, JRC, C van Schalkwyk, ...
Data and code for "Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in southern Africa has bee...
Objective: We aimed to compare clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlie...
Code for publication on SARS-CoV-2 reinfection. SARS-CoV-2 has extensively mutated creating variant...
OBJECTIVE: We aimed to compare clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlie...
Background: At present, it is unclear whether the extent of reduced risk of severe disease seen with...
BACKGROUND: The extent to which the reduced risk of severe disease seen with SARS-CoV-2 Omicron is d...
Data files for Pulliam, JRC, C van Schalkwyk, N Govender, A von Gottberg, C Cohen, MJ Groome, J Dush...
This version contains a single file, with time series data for the most recent monthly report on SAR...
This version contains a single file, with time series data for the most recent monthly report on SAR...
This version contains a single file, with time series data for the most recent monthly report on SAR...
This version contains a single file, with time series data for the most recent monthly report on SAR...
This version contains a single file, with time series data for the most recent monthly report on SAR...
This release is associated with Version 2 of the following preprint: Pulliam, JRC, C van Schalkwyk, ...
This release is associated with Version 3 of the following preprint: Pulliam, JRC, C van Schalkwyk, ...
Data and code for "Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in southern Africa has bee...
Objective: We aimed to compare clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlie...
Code for publication on SARS-CoV-2 reinfection. SARS-CoV-2 has extensively mutated creating variant...
OBJECTIVE: We aimed to compare clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlie...
Background: At present, it is unclear whether the extent of reduced risk of severe disease seen with...
BACKGROUND: The extent to which the reduced risk of severe disease seen with SARS-CoV-2 Omicron is d...